Zivo Bioscience Announces Board Changes and New CFO
Ticker: ZIVOW · Form: 8-K · Filed: Jul 17, 2024 · CIK: 1101026
| Field | Detail |
|---|---|
| Company | Zivo Bioscience, Inc. (ZIVOW) |
| Form Type | 8-K |
| Filed Date | Jul 17, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-composition
TL;DR
ZIVO board shakeup: 2 directors out, 2 new ones in, new CFO appointed. Big changes coming?
AI Summary
Zivo Bioscience, Inc. announced on July 11, 2024, a series of significant corporate actions including the departure of two directors, the election of two new directors, and the appointment of a new Chief Financial Officer. The company also disclosed compensatory arrangements for its officers.
Why It Matters
These changes in leadership and board composition can signal a shift in strategic direction or operational focus for Zivo Bioscience.
Risk Assessment
Risk Level: medium — Changes in board and executive leadership can introduce uncertainty regarding future strategy and performance.
Key Players & Entities
- Zivo Bioscience, Inc. (company) — Registrant
- July 11, 2024 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
FAQ
Who are the departing directors of Zivo Bioscience?
The filing indicates the departure of two directors, but their names are not explicitly listed in the provided text.
Who are the newly elected directors?
The filing states that two new directors have been elected, but their names are not specified in the provided text.
Who has been appointed as the new Chief Financial Officer?
The filing confirms the appointment of a new Chief Financial Officer, but the name is not provided in the text.
What is the exact date of the earliest event reported in this 8-K filing?
The earliest event reported is dated July 11, 2024.
What is Zivo Bioscience's state of incorporation?
Zivo Bioscience, Inc. is incorporated in Nevada.
Filing Stats: 724 words · 3 min read · ~2 pages · Grade level 11.5 · Accepted 2024-07-17 16:26:44
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share ZIVO OTCQB Warrants to p
Filing Documents
- zivo_8k.htm (8-K) — 26KB
- 0001654954-24-009069.txt ( ) — 160KB
- zivo-20240711.xsd (EX-101.SCH) — 6KB
- zivo-20240711_lab.xml (EX-101.LAB) — 15KB
- zivo-20240711_cal.xml (EX-101.CAL) — 1KB
- zivo-20240711_pre.xml (EX-101.PRE) — 11KB
- zivo-20240711_def.xml (EX-101.DEF) — 4KB
- zivo_8k_htm.xml (XML) — 5KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ZIVO BIOSCIENCE, INC. By: /s/ Keith Marchiando Keith Marchiando Chief Financial Officer Date: July 17, 2024 3